Implantable fluid delivery devices, systems, and methods

Information

  • Patent Grant
  • 10925644
  • Patent Number
    10,925,644
  • Date Filed
    Monday, October 9, 2017
    6 years ago
  • Date Issued
    Tuesday, February 23, 2021
    3 years ago
Abstract
Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.
Description
TECHNICAL FIELD

The present disclosure relates generally to implantable medical devices, and more particularly to devices, systems, and methods for delivering fluid to the uterus of a subject.


BACKGROUND

Medical devices may be used to deliver fluids (e.g., drugs or other fluids) to a patient or subject. Certain devices may be configured to be implanted at a patient site and deliver a fluid thereto. For example, intrauterine devices may be used to deliver fluids directly to the uterus of a patient, such as in an in vitro fertilization (IVF) procedure to increase the likelihood of pregnancy and/or to control certain aspects of a pregnancy.


However, devices that can be deployed in the uterus of a subject must have a particular size, shape, and design, which may be difficult to achieve for certain devices and/or fluid payloads. So while devices that are implantable in the uterus can dispense fluid, such as semen in an IVF procedure, directly to the surrounding tissue with a high probability of fluid delivery to the uterus, it is not feasible to design every fluid delivery device to be implanted in the uterus.


Intravaginal devices have fewer design limitations relating to the deployment site than intrauterine devices; however, if the device can only be placed within the vaginal cavity, dispensing a fluid to the uterus, such as semen in an IVF procedure, can be considerably more difficult. Accordingly, there is a need for improved intravaginal devices, systems, and methods that provide fluid delivery to the uterus of a subject.


SUMMARY

In one aspect, implantable fluid delivery devices are provided, including a housing configured for intravaginal deployment and retention in a subject, at least one reservoir associated with the housing and configured to contain a fluid, and a fluid dispensing mechanism disposed within the housing and configured to dispense the fluid from the at least one reservoir past the cervix and to the uterus of the subject.


In another aspect, implantable fluid delivery systems are provided, including a device having a housing configured for intravaginal deployment and retention in a subject and a fluid dispensing mechanism disposed within the housing; and a capsule containing a fluid to be delivered to the subject, the capsule being configured to be inserted past the cervix of the subject prior to deployment of the device, wherein the fluid dispensing mechanism includes an ultrasonic element configured to generate an ultrasonic wave effective to rupture the capsule and release the fluid to the uterus of the subject.


In yet another aspect, methods of delivering fluid to a subject are provided, including intravaginally deploying and retaining a device in the subject, the device including at least one reservoir containing a fluid and a fluid dispensing mechanism; and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.


In still yet another aspect, methods of delivering fluid to a subject are provided, including inserting a capsule containing a fluid to be delivered to the subject past the cervix of the subject; thereafter intravaginally deploying a device in the subject, the device including a fluid dispensing mechanism, which includes an ultrasonic element; and generating an ultrasonic wave, via the ultrasonic element, effective to rupture the capsule and release the fluid to the uterus of the subject.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A is a perspective view of an implantable fluid delivery device.



FIG. 1B is an exploded view of the implantable fluid delivery device of FIG. 1A.



FIG. 2 is a partial cross-sectional view of one embodiment of an implantable fluid delivery device.



FIG. 3 is a partial cross-sectional view of another embodiment of an implantable fluid delivery device.



FIG. 4 is a partial cross-sectional view of yet another embodiment of an implantable fluid delivery device.



FIG. 5A is a partial cross-sectional view of yet another embodiment of an implantable fluid delivery device having an extending member, shown in the unstressed position.



FIG. 5B is a partial cross-sectional view of the implantable fluid delivery device of FIG. 5A, showing the extending member in the extended position.



FIG. 5C is a magnified partial cross-sectional view of the implantable fluid delivery device of FIG. 5B.



FIG. 6 is a partial cross-sectional view of one embodiment of an implantable fluid delivery system.





DETAILED DESCRIPTION

The devices, systems, and methods described herein meet one or more of the above-stated needed by provided implantable fluid delivery to the uterus of a subject. In certain embodiments, an intravaginal device is provided that is capable of delivering a fluid past the cervix and to the uterus of a subject.


Such devices may be particularly useful in animals, such as cattle, where the IVF procedure has to be performed by a skilled professional and is a time-consuming, costly, and intensive procedure for each animal. The devices, systems, and methods disclosed herein increase the likelihood of success of each IVF procedure by increasing the precision of the fluid delivery. As such, the valuable sperm and the time commitment from these professionals may be most effectively and efficiently used.


Implantable Fluid Delivery Devices and Systems


In one aspect, implantable fluid delivery devices and systems are provided, which allow for the controlled dispense or release of one or more fluids to the uterus of a subject. In embodiments, the release or dispense is temporally controlled, such that the fluid substance reaches the uterus at a selected time.


In one embodiment, as shown in FIGS. 1A and 1B, an implantable fluid delivery device 100 includes a housing 102 configured for intravaginal deployment and retention in a subject. For example, the housing 102 of the device 100 may be sized and shaped for intravaginal deployment and retention in the subject. In one embodiment, the device 100 includes one or more retention features 104, for retaining the device intravaginally upon deployment.


For example, as shown in FIGS. 1A and 1B, depending on the fluid dispensing mechanism, and the power and actuation needs of the device, the device 100 may include a control system 114 that includes one or more of a power source 112, a microcontroller 110, and an actuation mechanism 108. In addition, the device 100 may include a fluid dispensing system 101, which alone or in combination with the control system, operates to dispense or release a fluid to the subject. The device 100 may also include a fluid dispensing feature 106, such as a nozzle or opening, which is associated with the housing 102. For example, the nozzle or opening may have a small diameter, such that the device is capable of delivering a thin stream or small droplets of the fluid at a high velocity.


In certain embodiments, as shown in FIGS. 2, 3, 4, and 5A-5C, the fluid dispensing system 201, 301, 401, 501 of the device includes at least one reservoir 220, 320, 420, 538 associated with the housing 202, 302, 402, 502 and configured to contain a fluid, and a fluid dispensing mechanism disposed within the housing 202, 302, 402, 502 and configured to dispense the fluid from the at least one reservoir 220, 320, 420, 538 past the cervix (shown as 534 in FIGS. 5A-5C) and to the uterus of the subject. Various fluid dispensing mechanisms may be utilized in these devices, some of which are discussed herein. Other suitable fluid dispensing mechanisms known to those of ordinary skill in the art, or modified versions of the fluid dispensing mechanisms disclosed herein, may also be utilized.


In certain embodiments, the fluid dispensing mechanism is an inkjet or other high-velocity fluid dispensing mechanism. For example, a thermal bubble or piezoelectric-type inkjet dispensing mechanism may be utilized. These mechanisms may advantageously propel the fluid out of the device at a high velocity such that the fluid is likely to penetrate, or pass, the cervix of the subject.


In one embodiment, as shown in FIG. 2, the fluid dispensing mechanism is a thermal bubble jet mechanism, which includes a bubble jet chamber 224 in fluid communication with the at least one reservoir 220, and a nozzle 206 in fluid communication with the bubble jet chamber 224. For example, the bubble jet chamber 224 may be connected to the reservoir 220 by a channel 222 or other suitable connection means. In the embodiment shown in FIG. 2, the thermal bubble jet mechanism is configured to generate heat in the bubble jet chamber 224 and thereby create a bubble of the fluid such that a droplet of the fluid is dispensed via the nozzle 206 upon expansion of the bubble.


In one embodiment, the thermal bubble jet mechanism is configured to generate heat in the bubble jet chamber via one or more resistors. In one embodiment, the thermal bubble jet mechanism is configured to generate a vacuum in the bubble jet chamber 224 such that fluid in the at least one reservoir 220 is drawn into the bubble jet chamber 224 upon collapse of the bubble.


In one embodiment, as shown in FIG. 3, the fluid dispensing mechanism comprises a piezoelectric jet mechanism, which includes a jet chamber 324 in fluid communication with the at least one reservoir 320. For example, the jet chamber 324 may be connected to the reservoir 320 by a channel 322 or other suitable connection means. The fluid dispensing mechanism shown in FIG. 3 also includes a piezoelectric material in communication with the jet chamber 324 and a nozzle 306 in fluid communication with the jet chamber 324. The piezoelectric material is configured to receive an electric charge causing it to vibrate and thereby drive fluid in the jet chamber 324 therefrom such that the fluid is dispensed via the nozzle 306.


In one embodiment, the piezoelectric jet mechanism is configured to generate a vacuum in the jet chamber 324 such that fluid from the at least one reservoir 320 is drawn into the jet chamber 324 upon dispense of fluid via the nozzle 306.


In one embodiment, as shown in FIG. 4, the fluid dispensing mechanism includes a high velocity pump, which includes a valve 428 configured to selectively allow flow of the fluid from the at least one reservoir 420 to a nozzle 406 and a pressure source 426 configured to drive the fluid from the at least one reservoir 420 toward the nozzle 406. In one embodiment, the valve 428 is configured to allow flow of the fluid from the at least one reservoir 420 to the nozzle 406 upon generation of a sufficient pressure in the at least one reservoir 420 via the pressure source 426, such that the fluid is dispensed via the nozzle 406. As used herein, the term “sufficient pressure” refers to a pressure that is great enough to drive the fluid from the intravaginally deployed device, past the cervix to the uterus of the subject.


For example, the nozzle 406 may be connected to the reservoir 420 by a channel 422 or other suitable connection means, at which a valve may be located to regulate flow of the fluid to the nozzle. For example, the valve may be actuated by electronics on board the device, such as the controller of the control system.


In one embodiment, the pressure source includes compressed gases, springs, pistons, or combinations thereof. For example, the pressure source may include, or be associated with, an actuation mechanism 108 of a control system 114, as shown in FIG. 1B.


In one embodiment, as shown in FIGS. 5A-5C, the at least one reservoir includes a tube 538 extending from a gas reservoir 536 of the device, and which includes at least one gas chamber 539, 540 configured to receive gas from the gas reservoir 536 to inflate and thereby urge the tube 538 into an extended position (shown in FIG. 5B). In one embodiment, the at least one gas chamber 539, 540 of the tube 538 is in fluid communication with the fluid contained in the tube such that as the gas chamber 539, 540 inflates, the fluid is driven out of the tube 538.


For example, the tube may include an end nozzle 506 via which the fluid is dispensed from the tube 538. In certain embodiments, the fluid has a surface tension within the tube such that the fluid is not dispensed from the open end of the tube until a sufficient pressure from the inflation of the gas chamber(s) is applied thereto. Alternatively, the end of the tube may include a barrier structure, such as an end cap or seal, configured to maintain the fluid inside the tube until a sufficient pressure from the inflation of the gas chamber(s) ruptures, disengages, or otherwise removes, the barrier structure, such that the fluid can be dispensed.


In one embodiment, as shown in FIG. 5B, the tube 538 is sized to extend past the cervix 534 of the subject in the extended position. That is, the tube 538 may be designed to have a length that extends from the intended vaginal implantation site past the cervix of the subject in which the device is to be implanted. In one embodiment, as shown in FIGS. 5A and 5B, the tube 538 is configured to have a coiled unstressed position and the extended position is an uncoiled position. For example, each of the chambers may be inflated as gas is released from the gas reservoir and the chamber(s) expand thereby forcing the tubing to uncoil. The gas released from the gas reservoir may also serve to drive the fluid from the tube during or upon uncoiling of the tube.


For example, in devices having the extendable tube dispensing mechanism, the velocity of the fluid being dispensed may be lower than that of fluid being dispensed from a device without such an extension tube, because the fluid is being dispensed past the cervix.


In certain embodiments, the tube may be coated with an anti-microbial or anti-wetting coating to prevent contaminants from flowing into the tube from the vaginal or uterine deployment site, or from one gas chamber to another.


In one embodiment, the tube includes at least two gas chambers in series along the tube that have a seal therebetween, such that the second gas chamber may only begin to inflate upon full or near full inflation of the first gas chamber of the tube.


In certain embodiments, a dispense tube is combined with the inkjet-type or high-velocity dispense devices described above. That is, a tube extending between the device and the cervix or uterus of a subject may be provided, either independently of the device (e.g., the tube may be inserted into the subject prior to deployment of the device) or in association with the device (e.g., in connection with the dispensing nozzle or outlet of the device), to ensure delivery of the fluid to the desired site, such as the uterus. Incorporation of such a tube into the device or system may decrease the required fluid velocity produced by the dispensing mechanism, because the fluid is dispensed past the cervix via the tube. In certain embodiments, the tube may be coated with an anti-microbial or anti-wetting coating to prevent contaminants from flowing into the tube from the vaginal or uterine deployment site.


In one embodiment, as shown in FIG. 6, an implantable fluid delivery system includes a device 600 having a housing 602 configured for intravaginal deployment and retention in a subject and a fluid dispensing mechanism 630 disposed within the housing 602. The device may include any of the features, or combinations of features, described herein. The system also includes a capsule 632 containing a fluid to be delivered to the subject, the capsule 632 being configured to be inserted past the cervix 632 of the subject prior to deployment of the device 600. In one embodiment, the fluid dispensing mechanism 630 includes an ultrasonic element configured to generate an ultrasonic wave effective to rupture the capsule 632 and release the fluid to the uterus of the subject. For example, the capsule may be inserted past the cervix of the subject manually, for example by ranch personnel in the case of cattle, or using a deployment device configured to deploy the capsule past the cervix.


In one embodiment, the ultrasonic element comprises a piezoelectric material and an acoustic horn.


Suitable device features, including housing designs, retention features, retrieval members, control system features, and additional fluid dispensing mechanisms (not configured for uteral delivery from an intravaginal device), are disclosed in application Ser. No. 13/629,124, filed on Sep. 27, 2012, entitled “Single Channel, Multiple Drug Delivery Device and Methods”, application Ser. No. 13/629,159, filed on Sep. 27, 2012, entitled “Multiple Reservoir Drug Delivery Device and Methods”, application Ser. No. 13/629,184, filed on Sep. 27, 2012, entitled “Drug Reconstitution and Delivery Device and Methods”, application Ser. No. 13/742,203, filed on Jan. 15, 2013, entitled “Devices and Methods for Intraluminal Retention and Drug Delivery”, application Ser. No. 14/071,929, filed on Nov. 5, 2013, entitled “Fluid Delivery Devices and Methods”, and application Ser. No. 14/107,367, filed on Dec. 16, 2013, entitled “Electrolytic Gas Generating Devices, Actuators, and Methods”, each of which is incorporated herein by reference in its entirety.


Advantageously, the devices and systems described herein provide for fluid dispensing to a site past the cervix, with a vaginally implanted device, thereby increasing the precision of the fluid delivery and the likelihood of delivery to the uterus. Desirably, in IVF procedures, these devices and systems increase the efficiency and the likelihood of success of procedures, requiring less time and sperm per subject.


In certain embodiments, the devices described herein may be configured to dispense the fluid when an estrus condition of the subject detected by the device meets a predetermined threshold. That is, the device may be configured to detect when the subject is displaying ideal or near ideal insemination conditions (i.e., estrus) and to dispense the fluid in response to the detection of estrus. Devices for detecting estrus are described in more detail in co-pending application Ser. No. 14/448,074, filed on Jul. 31, 2014, entitled “Implantable Estrus Detection Devices, Systems, and Methods,” which is incorporated herein by reference in its entirety.


In certain embodiments, the fluid includes drugs, semen, ova, or combinations thereof.


In certain embodiments, the fluid delivery devices disclosed herein may be configured to release two or more fluids therefrom, such as from separate reservoirs. For example, a device may be configured to dispense a series of drugs to the patient. For example, a device may be configured to dispense both an ova and semen to a patient.


Methods of Fluid Delivery


In another aspect, methods of delivering fluid to a subject are provided. For example, the methods may include deploying a fluid delivery device or system, such as those disclosed herein, in the subject. The devices and systems may include any features, or combinations of features, disclosed herein.


In one embodiment, a method of delivering fluid to a subject includes intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject. For example, the device may include at least one reservoir containing a fluid and a fluid dispensing mechanism.


In one embodiment, dispensing the fluid from the device includes heating a portion of the fluid in a chamber to create a bubble such that a droplet of the fluid is dispensed via a nozzle upon expansion of the bubble.


In one embodiment, dispensing the fluid from the device includes providing an electric charge to a piezoelectric material, thereby causing it to vibrate and drive a portion of the fluid from a chamber such that the portion of fluid is dispensed from the device through a nozzle.


In one embodiment, dispensing the fluid from the device includes generating pressure in the at least one reservoir to drive the fluid toward a nozzle, and the device also includes a valve configured to allow flow of the fluid from the at least one reservoir to the nozzle upon generation of sufficient pressure in the at least one reservoir. For example, the pressure source may include compressed gases, a springs, pistons, and combinations thereof.


In one embodiment, the at least one reservoir includes a tube extending from a gas reservoir of the device, which includes at least one gas chamber that is in fluid communication with the fluid contained in the tube, and the step of dispensing the fluid from the device includes inflating the at least one gas chamber of the tube with gas from a gas reservoir of the device, thereby urging the tube into an extended position and driving the fluid from the tube. For example, the tube may be sized to extend past the cervix of the subject in the extended position. In one embodiment, the tube is configured to have a coiled unstressed position, and the extended position is an uncoiled position.


In certain embodiments, a method of delivering fluid to a subject includes inserting a capsule containing a fluid to be delivered to the subject past the cervix of the subject, thereafter intravaginally deploying a device in the subject, the device comprising a fluid dispensing mechanism, which comprises an ultrasonic element, and generating an ultrasonic wave, via the ultrasonic element, effective to rupture the capsule and release the fluid to the uterus of the subject. In one embodiment, the ultrasonic element includes a piezoelectric material and an acoustic horn.


In one embodiment, dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject occurs after an estrus condition of the subject detected by the device meets a predetermined threshold. For example, the fluid may include drugs, semen, ova, and combinations thereof. In a particular embodiment, the subject is a horse, cow, sheep, or sow. In another embodiment, the subject is a woman.


It will be appreciated that variants of the above-disclosed and other features and functions, or alternatives thereof, may be combined into many other different devices, systems, methods, or applications. Various presently unforeseen or unanticipated alternatives, modifications, variations, or improvements therein may be subsequently made by those skilled in the art which are also intended to be encompassed by the following claims

Claims
  • 1. An implantable fluid delivery device, comprising: a housing configured for intravaginal deployment and retention in a subject;at least one reservoir associated with the housing and configured to contain a fluid; anda fluid dispensing mechanism disposed within the housing and configured to dispense the fluid from the at least one reservoir past the cervix and to the uterus of the subject.
  • 2. The device of claim 1, wherein the fluid dispensing mechanism comprises a thermal bubble jet mechanism, which comprises: a bubble jet chamber in fluid communication with the at least one reservoir; anda nozzle in fluid communication with the bubble jet chamber,wherein the thermal bubble jet mechanism is configured to generate heat in the bubble jet chamber and thereby create a bubble of the fluid such that a droplet of the fluid is dispensed via the nozzle upon expansion of the bubble.
  • 3. The device of claim 2, wherein the thermal bubble jet mechanism is configured to generate heat in the bubble jet chamber via one or more resistors.
  • 4. The device of claim 2, wherein the thermal bubble jet mechanism is configured to generate a vacuum in the bubble jet chamber such that fluid in the at least one reservoir is drawn into the bubble jet chamber upon collapse of the bubble.
  • 5. The device of claim 1, wherein the fluid dispensing mechanism comprises a piezoelectric jet mechanism, which comprises: a jet chamber in fluid communication with the at least one reservoir;a piezoelectric material in communication with the jet chamber; anda nozzle in fluid communication with the jet chamber,wherein the piezoelectric material is configured to receive an electric charge causing it to vibrate and thereby drive fluid in the jet chamber therefrom such that the fluid is dispensed via the nozzle.
  • 6. The device of claim 5, wherein the piezoelectric jet mechanism is configured to generate a vacuum in the jet chamber such that fluid from the at least one reservoir is drawn into the jet chamber upon dispense of fluid via the nozzle.
  • 7. The device of claim 1, wherein the fluid dispensing mechanism comprises a high velocity pump, which comprises: a valve configured to selectively allow flow of the fluid from the at least one reservoir to a nozzle; anda pressure source configured to drive the fluid from the at least one reservoir toward the nozzle,wherein the valve is configured to allow flow of the fluid from the at least one reservoir to the nozzle upon generation of a sufficient pressure in the at least one reservoir via the pressure source, such that the fluid is dispensed via the nozzle.
  • 8. The device of claim 7, wherein the pressure source is selected from the group consisting of compressed gases, springs, pistons, and combinations thereof.
  • 9. The device of claim 1, wherein the device is configured to dispense the fluid when an estrus condition of the subject detected by the device meets a predetermined threshold.
  • 10. The device of claim 1, wherein the fluid is selected from the group consisting of drugs, semen, ova, and combinations thereof.
  • 11. A method of delivering fluid to a subject, comprising: intravaginally deploying and retaining a device in the subject, the device comprising at least one reservoir containing a fluid and a fluid dispensing mechanism; anddispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.
  • 12. The method of claim 11, wherein dispensing the fluid from the device comprises heating a portion of the fluid in a chamber to create a bubble such that a droplet of the fluid is dispensed via a nozzle upon expansion of the bubble.
  • 13. The method of claim 11, wherein dispensing the fluid from the device comprises providing an electric charge to a piezoelectric material, thereby causing it to vibrate and drive a portion of the fluid from a chamber such that the portion of fluid is dispensed from the device through a nozzle.
  • 14. The method of claim 11, wherein: dispensing the fluid from the device comprises generating pressure in the at least one reservoir to drive the fluid toward a nozzle, andthe device further comprises a valve configured to allow flow of the fluid from the at least one reservoir to the nozzle upon generation of sufficient pressure in the at least one reservoir.
  • 15. The method of claim 14, wherein the pressure source is selected from the group consisting of compressed gases, springs, pistons, and combinations thereof.
  • 16. The method of claim 11, wherein: dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject occurs after an estrus condition of the subject detected by the device meets a predetermined threshold.
  • 17. The method of claim 11, wherein the fluid is selected from the group consisting of drugs, semen, ova, and combinations thereof.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. application Ser. No. 14/448,087, filed Jul. 31, 2014, which is incorporated herein by reference in its entirety.

US Referenced Citations (92)
Number Name Date Kind
3822702 Bolduc Jul 1974 A
4304232 Michaels Dec 1981 A
4308867 Roseman et al. Jan 1982 A
4402695 Wong Sep 1983 A
4687423 Maget et al. Aug 1987 A
4886514 Maget Dec 1989 A
4892778 Theeuwes et al. Jan 1990 A
4902278 Maget et al. Feb 1990 A
5002540 Brodman et al. Mar 1991 A
5062834 Gross et al. Nov 1991 A
5090963 Gross et al. Feb 1992 A
5112614 Magruder et al. Jun 1992 A
5135499 Tafani et al. Aug 1992 A
5162116 Shepherd et al. Sep 1992 A
5318557 Gross Jun 1994 A
5354264 Bae et al. Oct 1994 A
5415629 Henley May 1995 A
5522804 Lynn Jun 1996 A
5593552 Joshi et al. Jan 1997 A
5780058 Wong et al. Jul 1998 A
5816248 Anderson et al. Oct 1998 A
5928195 Malamud et al. Jul 1999 A
5951538 Joshi et al. Sep 1999 A
6030375 Anderson et al. Feb 2000 A
6086909 Harrison et al. Jul 2000 A
6139538 Houghton et al. Oct 2000 A
6183434 Eppstein Feb 2001 B1
6322532 D'Sa et al. Nov 2001 B1
6352524 Bunt Mar 2002 B1
6423039 Rathbone et al. Jul 2002 B1
6444224 Rathbone et al. Sep 2002 B1
6450991 Bunt et al. Sep 2002 B1
6532386 Sun et al. Mar 2003 B2
6591133 Joshi Jul 2003 B1
6638246 Naimark et al. Oct 2003 B1
6743211 Prausnitz et al. Jun 2004 B1
6756053 Zhang et al. Jun 2004 B2
6776164 Bunt et al. Aug 2004 B2
6805877 Massara et al. Oct 2004 B2
6835392 Hsu et al. Dec 2004 B2
6962579 Jellie Nov 2005 B2
6978172 Mori et al. Dec 2005 B2
7004171 Benita et al. Feb 2006 B2
7083575 Claycomb et al. Aug 2006 B1
7083590 Bunt et al. Aug 2006 B1
7486989 Sun et al. Feb 2009 B2
7497855 Ausiello et al. Mar 2009 B2
7732408 Josephson et al. Jun 2010 B2
9297083 Abhishek et al. Mar 2016 B2
9801660 Johnson Oct 2017 B2
20020010414 Coston et al. Jan 2002 A1
20020045883 Jellie et al. Apr 2002 A1
20020156394 Mehrotra Oct 2002 A1
20030018295 Henley et al. Jan 2003 A1
20030130558 Massara et al. Jul 2003 A1
20030219472 Paulelli et al. Nov 2003 A1
20040059388 Herbst et al. Mar 2004 A1
20040082937 Ausiello et al. Apr 2004 A1
20040087893 Kwon May 2004 A1
20040219192 Horstmann et al. Nov 2004 A1
20050000514 Sullivan et al. Jan 2005 A1
20050054969 Hoff et al. Mar 2005 A1
20050124875 Kawano et al. Jun 2005 A1
20050244502 Mathias et al. Nov 2005 A1
20050267440 Herman et al. Dec 2005 A1
20060024358 Santini et al. Feb 2006 A1
20060184092 Atanasoska et al. Aug 2006 A1
20070038181 Melamud et al. Feb 2007 A1
20070173711 Shah et al. Jul 2007 A1
20070225634 Ferren et al. Sep 2007 A1
20070269385 Yun et al. Nov 2007 A1
20080004564 Smith Jan 2008 A1
20080004596 Yun et al. Jan 2008 A1
20080171950 Franco Jul 2008 A1
20080262412 Atanasoska et al. Oct 2008 A1
20080269666 Wang et al. Oct 2008 A1
20090131737 Ferren et al. May 2009 A1
20090171315 Versi Jul 2009 A1
20090281528 Grovender Nov 2009 A1
20090306633 Trovato et al. Dec 2009 A1
20090308752 Evans Dec 2009 A1
20110087155 Uhland et al. Apr 2011 A1
20110087192 Uhland et al. Apr 2011 A1
20110087195 Uhland et al. Apr 2011 A1
20110092906 Boettger Apr 2011 A1
20120238912 Rajkondawar et al. Sep 2012 A1
20130211372 Rosenshein Aug 2013 A1
20140088345 Uhland et al. Mar 2014 A1
20140088346 Uhland et al. Mar 2014 A1
20140088486 Uhland et al. Mar 2014 A1
20140200553 Johnson et al. Jul 2014 A1
20150126968 Abhishek et al. May 2015 A1
Foreign Referenced Citations (12)
Number Date Country
4130843 Mar 1993 DE
9401165 Jan 1994 WO
9418952 Sep 1994 WO
9741831 Nov 1997 WO
0112101 Feb 2001 WO
2005056708 Jun 2005 WO
2005089728 Sep 2005 WO
2007041119 Apr 2007 WO
2007047811 Apr 2007 WO
2007140416 Dec 2007 WO
2009081411 Jul 2009 WO
2010048478 Apr 2010 WO
Non-Patent Literature Citations (16)
Entry
Boehmer et al., “Effects of Temperature of Consumed Water on Rumen Temperature of Beef Cows,” Oklahoma Agricultural Experiment Station, 2009, 4 pages.
Boehmer, “Ruminal Temperature for Identification and Prediction of Estrus in Beef Cows,” 2012, Thesis.
Heckman et al., “Estrous Cycle Patterns in Cattle Monitored by Electrical Resistance and Milk Progesterone,” 1979, J. Dairy Sci., 62:64-68.
de Mol et al., “Application of Fuzzy Logic in Automated Cow Status Monitoring,” 2001, J. Dairy Sci., 84:400-410.
O'Connor, “Heat Detection and Timing of Insemination for Cattle,” 1993, Pennsylvania State University, Extension Circular 402.
Piccione et al., “Daily and Estrous Rhythmicity of Body Temperature in Domestic Cattle,” 2003, BioMed Central, (8 pages).
Cooper-Prado et al., “Relationship of Ruminal Temperature with Parturition and Estrus of Beef Cows,” 2011, J. Anim. Sci., 89:1020-1027.
http://ww.beaconhd.com.au/heatseeker.html, Beacon Heat Detectors, accessed on Feb. 27, 2014.
http://www.twilcanada.com/estrus-detector.php, Estrus Detector, accessed on Feb. 27, 2014.
http://www.cowchips.net/, How HeatWatch II Works, accessed on Feb. 27, 2014.
Bridges, et al., “Timed-Artificial Insemination in Beef Cows: What are the Options?,” Purdue University Cooperative Extension Service, West Lafayette, IN (Rev Mar. 2008).
Fatakdawala, Hussain et al., “Hydrogen peroxide mediated transvaginal drug delivery,” International Journal of Pharmaceutics 409 (2011) 121-127.
Hashimoto et al., “Oxidative stress induces gastric epithelial permeability through claudin-3.” Biochemical and Biophysical Research Communications (2008), vol. 376, pp. 154-157.
Kadajji, et al., “Water Soluble Polymers for Pharmaceutical Applications.” Polymers (2011), vol. 3, pp. 1972-2009.
Sáfilho, O. G. et al., “Fixed-time artificial insemination with estradiol and progesterone for Bos indicus cows II: Strategies and factors affecting fertility,” Science Direct, Theriogenology 72 (2009) 210-218.
Seth, et al., “Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC-and MAP kinase-dependent mechanism,” Am J Physiol Gastrointest Liver Physiol (2008), vol. 294, pp. G1060-G1069. Retrieved from http://www.ajpgi.org on Jul. 28, 2009.
Related Publications (1)
Number Date Country
20180028228 A1 Feb 2018 US
Divisions (1)
Number Date Country
Parent 14448087 Jul 2014 US
Child 15727766 US